Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
96studies shown
Showing 25-36 of 96
Other study type icon
Enrolling By InvitationNCT05841212

DBT Skills Group for Adolescents with ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 13 Years to 16 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
ADHD
Other study type icon
Not Yet RecruitingNCT07570381

Biomarkers of ASD/ADHD and Factors Affecting Anxiety and Depression in Children and Young Adults

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHD, Depression, ...ObservationalA study where researchers collect information without assigning a treatment.From 6 Months to 25 Years
Countries
United Kingdom
Sponsor
University of Exeter
Condition
ADHD, Depression, ...
Behavioral study icon
CompletedNCT00447278

A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents

This study is completed in France, in the United Kingdom, in Belgium, .... It focuses on ADHD.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDBehavioralFrom 6 Years to 16 Years
Countries
France, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
ADHD
Drug study icon
CompletedNCT00714688

Effectiveness of Effectiveness and Safety of Prolonged Release OROS Methylphenidate in ADHD

This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Effectiveness and Safety of Prolonged Release OROS Methylphenidate for ADHD.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Janssen-Cilag International NV
Condition
ADHD
Other study type icon
CompletedNCT01470261

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDObservationalFrom 5 Years to 17 Years
Countries
United Kingdom, Germany, Hungary, ...
Sponsor
NHS Tayside
Condition
ADHD
Behavioral study icon
Active Not RecruitingNCT07541820

Tailored Yoga Therapy for Attention-deficit Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDBehavioralOver 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
ADHD
Drug study icon
Not recruitingISRCTN48265228

Brain stimulation combined with cognitive training in attention deficit hyperactivity disorder

This study is looking at whether a digital support tool can help people with Attention deficit hyperactivity disorder, Mental and Behavioural Disorders, or Disturbance of activity and attention. Participants take part in a digital support tool and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 10 Years to 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
ADHD
Drug study icon
CompletedEUCTR 2011-004668-31

A Phase 3, Open-label, Multicentre, Protocol to Provide Access to Guanfacine Hydrochloride Extended Release for European Subjects with Attention-deficit/Hyperactivity Disorder (ADHD) who Participat...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
United Kingdom, Belgium, Austria, ...
Sponsor
Shire Pharmaceutical Development Ltd
Condition
ADHD
Drug study icon
CompletedEUCTR 2010-020951-30

A Phase 4, Open-label, Multicentre, 2-Year Safety Study of Lisdexamfetamine Dimesylate in Children and Adolescents Aged 6-17 Years with Attention-Deficit/Hyperactivity Disorder (ADHD)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
United Kingdom, Belgium, Germany, ...
Sponsor
Shire Pharmaceutical Development Ltd
Condition
ADHD
Drug study icon
CompletedEUCTR 2010-024551-82

OPEN LABEL TRIAL OF ATOMOXETINE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN WITH 22q11.2 DELETION SYNDROME (22qDS)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.